BackIterum Therapeutics Plc Overview

Iterum Therapeutics Plc Current Assets

Track Iterum Therapeutics Plc's current assets ($14M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$13.73M
13.42% YoYΔ $-2.13M vs prior year quarter

Peer trimmed avg / median

Loading

Iterum Therapeutics Plc Current Assets History

Loading

Iterum Therapeutics Plc vs. peers: Current Assets Comparison

Loading

Iterum Therapeutics Plc Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Iterum Therapeutics Plc (ITRM) FAQ

As of the most recent data (September 2025), ITRM shows a current assets of $14M. That compares with $16M in the prior-year period — down 13.4% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ITRM's current assets is now $14M (was $16M) — a 13.4% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Iterum Therapeutics Plc is outperforming or lagging.

Tracking ITRM's current assets over time shows whether Iterum Therapeutics Plc is scaling, shrinking, or reshaping that part of the business. The current reading is $14M That compares with $16M in the prior-year period — down 13.4% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current assets page, Stockcircle has Iterum Therapeutics Plc's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current assets (currently $14M) with ownership activity and broader fundamentals.

Iterum Therapeutics Plc's current assets is $14M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.